Crossmark

Quantitative assessment of the breast cancer marker HER2 using a gold nanoparticle-based lateral flow immunoassay

Published Online: 2024-02-01

Published Print: 2024-06

Authors

Ye, Liya

Xu, Xinxin

Qu, Aihua

Liu, Liqiang

Xu, Chuanlai

Kuang, Hua
License Information

Text and Data Mining valid from 2024-02-01

Version of Record valid from 2024-02-01
More Information

Article History

Received: 29 November 2023

Revised: 26 December 2023

Accepted: 3 January 2024

First Online: 1 February 2024

Document is current